New Developments in Cardiac Pacemakers

For >50 years, bradycardic patients have enjoyed the benefits of cardiac pacing, a therapy that can improve and, in some instances, prolong their lives. Although initially this unique electric therapy aimed just to maintain an acceptable cardiac output that would support life, contemporary pacemakers mimic the function of the native conduction system of the heart ever more closely while eliminating disturbances of the production and propagation of the electric impulse. Pacemakers nowadays are able to ensure atrioventricular (AV) synchrony and to adapt the heart rate according to the peripheral tissue energy demand while incorporating a large number of useful algorithms. In addition, they have the ability to record and store cardiac electrograms, providing valuable information about other rhythm disturbances such as atrial fibrillation (AF) or ventricular arrhythmias that are not uncommon in paced patients. At the same time, a better understanding of the natural history of bradyarrhythmias and the recently published results of large, randomized, controlled trials have enabled us to revise older guidelines, to develop new indications for cardiac pacing, and to optimize the selection of the proper pacing mode for each indication on the basis of existing evidence. Finally, in an attempt to minimize iatrogenic adverse effects caused by pacing from the right ventricular apex (RVA) and right atrial appendage (RAA) and to improve the outcome of cardiac pacing, alternative pacing sites are under evaluation, and leadless pacing and biological pacemakers are among the expectations for the future. Most pacemakers worldwide are implanted because of AV block and sick sinus syndrome (SSS); other indications such as bundle-branch block and neurally mediated syncope are less common. Even more rarely, pacing is done to improve hemodynamics, as in first-degree AV block with a very long PR interval or in hypertrophic obstructive cardiomyopathy, and for indications for specific diseases such as …

[1]  E. Donoso,et al.  NONSURGICAL ACQUIRED HEART BLOCK * , 1963, Annals of the New York Academy of Sciences.

[2]  Johansson Bw Complete heart block. A clinical, hemodynamic and pharmacological study in patients with and without an artificial pacemaker. , 1966 .

[3]  O. Edhag Long-term cardiac pacing. Experience of fixed-rate pacing with an endocardial electrode in 260 patients. , 1969, Acta medica Scandinavica. Supplementum.

[4]  Å. Swahn,et al.  Prognosis of patients with complete heart block or arrhythmic syncope who were not treated with artificial pacemakers. A long-term follow-up study of 101 patients. , 2009, Acta medica Scandinavica.

[5]  P. Samet,et al.  Electrophysiologic evaluation of elderly patients with sinus bradycardia: a long-term follow-up study. , 2020, Annals of internal medicine.

[6]  J. Gowers,et al.  Survival in sinoatrial disorder (sick-sinus syndrome). , 1980, British medical journal.

[7]  S. Swiryn,et al.  Natural History of Chronic Second‐degree Atrioventricular Nodal Block , 1981, Circulation.

[8]  G. Flaker,et al.  Carotid sinus hypersensitivity: beneficial effects of dual-chamber pacing. , 1984, The American journal of cardiology.

[9]  R. Kenny,et al.  The Natural History of Sick Sinus Syndrome , 1986, Pacing and clinical electrophysiology : PACE.

[10]  M. Brignole,et al.  Is DDD Superior to VVI Pacing in Mixed Carotid Sinus Syndrome? An Acute and Medium‐Term Study , 1988, Pacing and clinical electrophysiology : PACE.

[11]  R. Sutton PACING IN PATIENTS WITH CAROTID SINUS AND VASOVAGAL SYNDROMES , 1989 .

[12]  A. Camm,et al.  Symptomatology and quality of life in patients with rate‐responsive pacemakers: A double‐blind, randomized, crossover study , 1989, Clinical cardiology.

[13]  K. Ellenbogen,et al.  New insights into pacemaker syndrome gained from hemodynamic, humoral and vascular responses during ventriculo-atrial pacing. , 1990, The American journal of cardiology.

[14]  H. Müderrisoğlu,et al.  Quality of Life in Patients with Rate Responsive Pacemakers: A Randomized, Cross‐Over Study , 1991, Pacing and clinical electrophysiology : PACE.

[15]  N Sulke,et al.  A randomized double-blind crossover comparison of four rate-responsive pacing modes. , 1991, Journal of the American College of Cardiology.

[16]  L. Thuesen,et al.  Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome , 1994, The Lancet.

[17]  MagnusMichaëlsson,et al.  Isolated Congenital Complete Atrioventricular Block in Adult Life , 1995 .

[18]  A. Tajik,et al.  Mechanism of hemodynamic improvement by dual-chamber pacing for severe left ventricular dysfunction: an acute Doppler and catheterization hemodynamic study. , 1995, Journal of the American College of Cardiology.

[19]  A. Jonzon,et al.  Isolated congenital complete atrioventricular block in adult life. A prospective study. , 1995, Circulation.

[20]  D. Steinhaus,et al.  Mobitz Type I Atrioventricular Block: An Indication for Permanent Pacing? , 1996, Pacing and clinical electrophysiology : PACE.

[21]  S. Barold Indications for Permanent Cardiac Pacing in First‐Degree AV Block: Class I, II, or III? , 1996, Pacing and clinical electrophysiology : PACE.

[22]  C. Morillo,et al.  The pacemaker syndrome -- a matter of definition. , 1997, The American journal of cardiology.

[23]  R. Cappato,et al.  Effects of permanent pacemaker and oral theophylline in sick sinus syndrome the THEOPACE study: a randomized controlled trial. , 1997, Circulation.

[24]  L. Thuesen,et al.  Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome , 1997, The Lancet.

[25]  Vince Paul,et al.  Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. , 1999, The American journal of cardiology.

[26]  S. Connolly,et al.  The North American Vasovagal Pacemaker Study (VPS). A randomized trial of permanent cardiac pacing for the prevention of vasovagal syncope. , 1999, Journal of the American College of Cardiology.

[27]  Quality of Life and Clinical Outcomes in Elderly Patients Treated with Ventricular Pacing as Compared with Dual-Chamber Pacing , 1999 .

[28]  C. Lau,et al.  Developments in sensor-driven pacing. , 2000, Cardiology clinics.

[29]  M Gent,et al.  Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes , 2000 .

[30]  G. Lamas,et al.  Clinical characteristics of patients intolerant to VVIR pacing. , 2000, The American journal of cardiology.

[31]  M. Brignole,et al.  Dual-chamber pacing in the treatment of neurally mediated tilt-positive cardioinhibitory syncope : pacemaker versus no therapy: a multicenter randomized study. The Vasovagal Syncope International Study (VASIS) Investigators. , 2000, Circulation.

[32]  J. Nanas,et al.  Congestive heart failure treated by the upgrade from VVI to DDD pacing , 2000, Acta cardiologica.

[33]  M. Santini,et al.  Permanent Cardiac Pacing Versus Medical Treatment for the Prevention of Recurrent Vasovagal Syncope: A Multicenter, Randomized, Controlled Trial , 2001, Circulation.

[34]  S. Adler,et al.  Prevention of Chronic Atrial Fibrillation by Pacing in the Region of Bachmann's Bundle: Results of a Multicenter Randomized Trial , 2001, Journal of cardiovascular electrophysiology.

[35]  D. Wyse,et al.  Improved suppression of recurrent atrial fibrillation with dual-site right atrial pacing and antiarrhythmic drug therapy. , 2002, Journal of the American College of Cardiology.

[36]  L. Goldman,et al.  Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. , 2002, The New England journal of medicine.

[37]  David O. Martin,et al.  Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. , 2002, JAMA.

[38]  G. Lamas,et al.  Atrial High Rate Episodes Detected by Pacemaker Diagnostics Predict Death and Stroke: Report of the Atrial Diagnostics Ancillary Study of the MOde Selection Trial (MOST) , 2003, Circulation.

[39]  J. Nielsen,et al.  A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. , 2003, Journal of the American College of Cardiology.

[40]  S. Connolly,et al.  Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II): a randomized trial. , 2003, JAMA.

[41]  G. Lamas,et al.  Adverse Effect of Ventricular Pacing on Heart Failure and Atrial Fibrillation Among Patients With Normal Baseline QRS Duration in a Clinical Trial of Pacemaker Therapy for Sinus Node Dysfunction , 2003, Circulation.

[42]  S. Connolly,et al.  Canadian Trial of Physiological Pacing: Effects of Physiological Pacing During Long-Term Follow-Up , 2004, Circulation.

[43]  A. Wear CIRCULATION , 1964, The Lancet.

[44]  P. Vardas,et al.  Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation. , 2004, Journal of the American College of Cardiology.

[45]  M. Brignole,et al.  A randomized, double-blind, placebo-controlled study of permanent cardiac pacing for the treatment of recurrent tilt-induced vasovagal syncope. The vasovagal syncope and pacing trial (SYNPACE). , 2004, European heart journal.

[46]  A. Camm,et al.  Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. , 2005, The New England journal of medicine.

[47]  A. J. Camm,et al.  Single-Chamber Versus Dual-Chamber Pacing for High-Grade Atrioventricular Block , 2005 .

[48]  C. Israel,et al.  Reducing Unnecessary Right Ventricular Pacing with the Managed Ventricular Pacing Mode in Patients with Sinus Node Disease and AV Block , 2006, Pacing and clinical electrophysiology : PACE.

[49]  F. Prinzen,et al.  A new paradigm for physiologic ventricular pacing. , 2006, Journal of the American College of Cardiology.

[50]  L. Di Biase,et al.  Is a Dual‐Sensor Pacemaker Appropriate in Patients with Sino‐Atrial Disease? Results from the DUSISLOG Study , 2006, Pacing and clinical electrophysiology : PACE.

[51]  R. van Mechelen,et al.  Risk of managed ventricular pacing in a patient with heart block. , 2006, Heart rhythm.

[52]  W. Boute,et al.  Retrospective analysis of mode survival, reliability of atrial sensing and incidence of atrial tachyarrhythmias in 307 single-lead VDD pacemaker patients. , 2006, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[53]  P. Vardas,et al.  Lack of correlation between the responses to tilt testing and adenosine triphosphate test and the mechanism of spontaneous neurally mediated syncope. , 2006, European heart journal.

[54]  L. Goldman,et al.  Cardiovascular Outcomes With Atrial-Based Pacing Compared With Ventricular Pacing: Meta-Analysis of Randomized Trials, Using Individual Patient Data , 2006, Circulation.

[55]  Richard Sutton,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[56]  M. Brignole,et al.  Cardioinhibitory carotid sinus hypersensitivity predicts an asystolic mechanism of spontaneous neurally mediated syncope. , 2007, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[57]  J. Daubert,et al.  Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. , 2007, European heart journal.

[58]  M. Zellweger,et al.  Value of VDD-pacing systems in patients with atrioventricular block: experience over a decade. , 2007, International journal of cardiology.

[59]  Paul A. Belk,et al.  Bradycardia pacing-induced short-long-short sequences at the onset of ventricular tachyarrhythmias: a possible mechanism of proarrhythmia? , 2007, Journal of the American College of Cardiology.

[60]  G. Lamas,et al.  Impact of rate-modulated pacing on quality of life and exercise capacity--evidence from the Advanced Elements of Pacing Randomized Controlled Trial (ADEPT). , 2007, Heart rhythm.

[61]  G. Lamas,et al.  Minimizing ventricular pacing to reduce atrial fibrillation in sinus-node disease. , 2007, The New England journal of medicine.

[62]  Harlan M Krumholz,et al.  ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.

[63]  V. Schibgilla,et al.  Primary Prevention of Atrial Fibrillation: Does the Atrial Lead Position Influence the Incidence of Atrial Arrhythmias in Patients with Sinus Node Dysfunction? Results from the PASTA Trial , 2009, Pacing and clinical electrophysiology : PACE.

[64]  Cheuk-Man Yu,et al.  Biventricular pacing in patients with bradycardia and normal ejection fraction. , 2009, The New England journal of medicine.

[65]  Daniel Levy,et al.  Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block. , 2009, JAMA.

[66]  Dongfeng Qi,et al.  The Relationship Between Daily Atrial Tachyarrhythmia Burden From Implantable Device Diagnostics and Stroke Risk: The TRENDS Study , 2009, Circulation. Arrhythmia and electrophysiology.

[67]  D. Slotwiner,et al.  Frequent Recurrent Polymorphic Ventricular Tachycardia during Sleep Due to Managed Ventricular Pacing , 2009, Pacing and clinical electrophysiology : PACE.

[68]  A. Gillis,et al.  562 Natural history of MVP mode in a single centre cohort , 2011 .

[69]  R. Ruiz-Granell,et al.  Diagnosis, management, and outcomes of patients with syncope and bundle branch block , 2011, European heart journal.

[70]  W. Toff,et al.  A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. , 2011, European heart journal.

[71]  Finn Gustafsson,et al.  2010 Focused Update of ESC Guidelines on Device Therapy in Heart Failure , 2011 .

[72]  A. Moss,et al.  Long-term implications of cumulative right ventricular pacing among patients with an implantable cardioverter-defibrillator. , 2011, Heart rhythm.

[73]  G. Lamas,et al.  The Influence of Atrial and Ventricular Pacing on the Incidence of Atrial Fibrillation: A Meta‐Analysis , 2011, Pacing and clinical electrophysiology : PACE.

[74]  M. S. Baccillieri,et al.  Efficacy of Low Interatrial Septum and Right Atrial Appendage Pacing for Prevention of Permanent Atrial Fibrillation in Patients With Sinus Node Disease: Results From the Electrophysiology-Guided Pacing Site Selection (EPASS) Study , 2011, Circulation. Arrhythmia and electrophysiology.

[75]  M. Brignole,et al.  The natural history of carotid sinus syncope and the effect of cardiac pacing. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[76]  C. Lau,et al.  Effects of right low atrial septal vs. right atrial appendage pacing on atrial mechanical function and dyssynchrony in patients with sinus node dysfunction and paroxysmal atrial fibrillation. , 2011, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[77]  W. Shen,et al.  Method of Pacing Does Not Affect the Recurrence of Syncope in Carotid Sinus Syndrome , 2012, Pacing and clinical electrophysiology : PACE.

[78]  Pacemaker Therapy in Patients with Neurally Mediated Syncope and Documented Asystole , 2012 .

[79]  D. Singer,et al.  Detection of previously undiagnosed atrial fibrillation in patients with stroke risk factors and usefulness of continuous monitoring in primary stroke prevention. , 2012, The American journal of cardiology.

[80]  A. Russo,et al.  HRS/ACCF expert consensus statement on pacemaker device and mode selection. , 2012, Journal of the American College of Cardiology.

[81]  G. Amit,et al.  Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[82]  J. Halperin,et al.  Subclinical atrial fibrillation and the risk of stroke. , 2012, The New England journal of medicine.

[83]  Lluís Mont,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.